Liat Hadad Simhayoff
Plus aucun poste en cours
Profil
Ms. Liat H.
Simhayoff is Chief Financial Officer at Hadasit Bio-Holdings Ltd., VP-Business Development & Marketing at Israel Biomedical Innovations Ltd., and VP-Marketing & Business Development at Allium Medical Solutions Ltd.
She is on the Board of Directors at Tikcro Technologies Ltd.
She received her undergraduate degree from Tel-Aviv University, an undergraduate degree from The Open University, and an MBA from Tel-Aviv University.
Anciens postes connus de Liat Hadad Simhayoff
| Sociétés | Poste | Fin |
|---|---|---|
| ALLMED SOLUTIONS LTD | Sales & Marketing | - |
| HBL - HADASIT BIO-HOLDINGS LTD | Directeur Financier/CFO | - |
| TIKCRO TECHNOLOGIES LTD. | Directeur/Membre du Conseil | - |
I.B.I Israel Biomedical Innovations Ltd.
 I.B.I Israel Biomedical Innovations Ltd. Medical SpecialtiesHealth Technology I.B.I Israel Biomedical Innovations Ltd. provides surgical and medical solutions specifically for gynecology, urology and gastroenterology. The company was founded in 2004 and is headquartered in Haogen, Israel. | Sales & Marketing | - |
Formation de Liat Hadad Simhayoff
| Tel-Aviv University | Masters Business Admin |
| The Open University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HBL - HADASIT BIO-HOLDINGS LTD | Finance |
| ALLMED SOLUTIONS LTD | Health Technology |
| Entreprise privées | 2 |
|---|---|
I.B.I Israel Biomedical Innovations Ltd.
I.B.I Israel Biomedical Innovations Ltd. Medical SpecialtiesHealth Technology I.B.I Israel Biomedical Innovations Ltd. provides surgical and medical solutions specifically for gynecology, urology and gastroenterology. The company was founded in 2004 and is headquartered in Haogen, Israel. | Health Technology |
Tikcro Technologies Ltd.
 Tikcro Technologies Ltd. BiotechnologyHealth Technology Tikcro Technologies Ltd. operates as a biopharmaceutical company. It pursues an early stage biotechnology project generating new antibodies for cancer treatment addressing immune modulation. This project is based on technology from the Weizmann Institute of Science in Israel. It promotes a new approach for the generation of antibodies which are expected to have selectivity and blocking capabilities and, as a result, are expected to effectively modulate the immune system. Tikcro Technologies was founded on December 14, 1999 and is headquartered in Hadera, Israel. | Health Technology |
